Leukaemia drug effective in treating breast cancer metastatic relapse
A mice study showed promising results in treating secondary recurrence of breast cancer in lungs
Drugs
Health
Medical
Drugs
Medical
Pharma
Pfizer to buy Seagen for $43 billion to fortify cancer portfolio
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
Drugs
Pharma
Redx, Jounce to merge in a $425 million all-share deal
Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new.
Drugs
Health
Pharma
Embedded LEDs may aid future cancer immunotherapies
Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.
Drugs
Medical
Pharma
GE Healthcare recalls 688 medical systems, FDA says ‘most serious’
GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe.
Drugs
Pharma
FDA puts on hold Blueprint Medicines’ clinical trial for solid cancers
The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according.
Drugs
Medical
Pharma
Blood cancer therapy may help to treat ovarian cancer: Swedish scientists
A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.
Drugs
Pharma
BioNTech to invest $43 million in new mRNA facility
BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.
Medical
Pharma
BioNTech signs MoU with UK govt to start clinical trials for mRNA cancer vaccine
BioNTech signs MoU with the British government to start mRNA cancer trials
Drugs
Pharma
Aurobindo Pharma gets FDA nod for injection to treat cancer
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.